UltraShort Nasdaq Biotechnology (bis)
Last Updated by Anonymous | Update This Page Now
►Summary | Add New ETF | Feedback
Asset Allocation (% of Port)
| US Stocks Non-US Stocks Bonds Cash Other |
% % % % % |
Geographic Allocation (% of Port)
| North America Europe Asia South America Africa Australia + Pacific Islands |
ETF Description Update
UltraShort Nasdaq Biotechnology (BIS) Description: BIS is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. BIS exchange trading fund (ETF) tracks the Biotechnology (-200%); this equity index contains nsdq listed companies classified as either biotechnology or pharmaceuticals companies. UltraShort Nasdaq Biotechnology (BIS) falls under the Leveraged Equities category. BIS's dividend yield is roughly 0%, it has an expense ratio of 0.95%, and is in the equity ETF asset class. UltraShort Nasdaq Biotechnology (BIS) focuses its investments in the U.S. region of the world. BIS has an ETF leverage of two times (2x) and the performance of the BIS ETF is inversely-related to its benchmark; in other words, BIS is short the index. The BIS ETF belongs to the Health & Biotech sector. An investor can find BIS's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features BIS's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on ProShares ETF funds or see the ETF research & analysis home page to start.
Portfolio Strategy
Be the first to explain UltraShort Nasdaq Biotechnology (BIS)'s strategy.
Post preview:
Close preview